LanzaTech Global (NASDAQ:LNZA) reported second-quarter 2026 revenue that was broadly flat from a year earlier, while sharply lower operating expenses helped narrow its adjusted EBITDA loss as the company continues shifting from an R&D-led model toward project development and…
mmercialization. The company reported second-quarter revenue of $9 million, compared with $9.1 million in the same quarter of 2025
Operating expenses declined 67% to $11.7 million from $35.1 million, while adjusted EBITDA loss narrowed to $7.6 million from a loss of $29.7 million a year earlier. Chief Executive Officer Jennifer Holmgren said the quarterly results reflected “a meaningful transformation in the business,” citing more stable revenue, a reduced operating expense base and improved adjusted EBITDA. She said LanzaTech has reduced headcount, renegotiated contracts and redirected spending toward commercialization priorities.
Revenue Mix and Cost Reductions For the second quarter, LanzaTech recorded $3.9 million in biorefining revenue, $1.3 million from joint development and contract research, and $3.8 million in CarbonSmart product revenue. Biorefining revenue increased from $2.9 million in the prior-year period, driven by higher engineering and other services revenue. Joint development and contract research revenue declined from $2.3 million as projects with existing customers were completed.